Clinical investigation of medicinal products in the treatment of depression - Scientific guideline
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-9 April 2025
PSUSA/00000742/202408
PSUSA/00000986/202409
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2025
Human medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 15, Status: Authorised
Composition of the Emergency Task Force (ETF) for preparedness
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Rules of procedure of the Emergency Task Force (ETF)